Ribomustin Injection 1's
₹9020*
MRP ₹11000
18% off
₹9350*
MRP ₹11000
15% CB
₹1650 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Ribomustin Injection 1's belongs to a class of anti-cancer medicines used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. This medicine is used in the treatment of Chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin’s leukemia (NHL) that has progressed during six months of treatment with rituximab or rituximab-containing treatment.
Ribomustin Injection 1's contains Bendamustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis.
Ribomustin Injection 1's may cause certain side effects, such as nausea, vomiting, diarrhea, stomach pain, anorexia, decreased weight, constipation, fever, decreased platelet count, fatigue, cough, headache, rash, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Ribomustin Injection 1's. Hence, do not self-administer.
Ribomustin Injection 1's should be avoided if you are allergic to it or any other components present in it. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, cardiac disorders, cancer, active infections, skin problems, or any allergic conditions. Ribomustin Injection 1's is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.
Ribomustin Injection 1's contains Bendamustine, which belongs to the class of alkylating agents. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. This medicine is used in the treatment of chronic lymphocytic leukemia and non-Hodgkin’s leukemia.
Ribomustin Injection 1's should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, cardiac disorders, cancer, active infections, skin problems, or any allergic conditions. Ribomustin Injection 1's may cause myelosuppression, active infections, severe skin reactions, tumor lysis syndrome (tumor cells release their contents into the bloodstream), other malignancies, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Ribomustin Injection 1's may cause embryo-fetal toxicity. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Ribomustin Injection 1's is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions: Ribomustin Injection 1's may interact with vaccines, CYP1A2 inhibitors (ketoconazole, clopidogrel, ritonavir, imipramine, clozapine), CYP1A2 inducers (Cimetidine, rifampicin, verapamil, phenytoin), monoclonal antibodies ((etanercept, baricitinib, certolizumab, golimumab, infliximab), vaccines and other medicines.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, skin diseases, and infections before receiving Ribomustin Injection 1's.
Indolent B-cell Non-Hodgkin’s Leukemia: Non-Hodgkin’s disease or Non-Hodgkin’s lymphoma is a blood cancer that affects your lymph system. It causes the uncontrollable growth of cancer cells in the lymph nodes. The lymph system is a part of the immune system which protects your body from disease and infections. In indolent B cell Non-Hodgkin’s lymphoma, the cancer cells grow slowly in the B lymphocytes. Symptoms include lymph node swelling, abdominal pain, chest pain, cough, fever, and night sweats.
Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Country of origin
Alcohol
Caution
Limit or avoid consumption of alcohol as it may worsen your condition.
Pregnancy
Unsafe
Ribomustin Injection 1's is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Ribomustin Injection 1's. Use reliable methods of birth control while on treatment with Ribomustin Injection 1's.
Breast Feeding
Caution
If you are a nursing mother, inform your doctor before receiving Ribomustin Injection 1's. You should not breastfeed while on treatment with Ribomustin Injection 1's.
Driving
Not applicable
-
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Ribomustin Injection 1's. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. Ribomustin Injection 1's is not recommended for use in patients with severe liver disease.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Ribomustin Injection 1's. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. This medicine should be avoided for patients with CrCl <40 ml/min.
Children
Unsafe
Ribomustin Injection 1's is not recommended for use in children as the safety and efficacy is not established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information